There are 2789 resources available
146P - Prognostic impact of HER2-low expression according to the oncotype Dx recurrence score in hormone receptor-positive early breast cancer
Presenter: Raz Mutai
Session: ePoster Display
147P - Genomic profile and response prediction of eribulin mesylate-based neoadjuvant chemotherapy in triple-negative breast cancer patients
Presenter: Tomomi Nishimura
Session: ePoster Display
148P - Phase III study of everolimus or placebo in addition to adjuvant hormone therapy for high risk early breast cancer: Subgroup analysis of the UCBG UNIRAD trial
Presenter: Paul Cottu
Session: ePoster Display
149P - Can high Ki67 predict distant recurrence in early stage breast cancer with low oncotype Dx score?
Presenter: Parvaneh Fallah
Session: ePoster Display
150P - Dysregulation of immune checkpoint proteins in newly-diagnosed early breast cancer patients
Presenter: Bernardo Rapoport
Session: ePoster Display
151P - The impact of limb hypothermia on the incidence and severity of paclitaxel induced peripheral neuropathy in breast cancer patients
Presenter: Alzahraa Azab
Session: ePoster Display
152P - Meta-analysis of the prognostic value of circulating tumor DNA (ctDNA) in patients (pts) with early breast cancer (EBC)
Presenter: Nadia Saoudi Gonzalez
Session: ePoster Display
153P - Adjuvant endocrine therapy combined with abemaciclib in monarchE patients with high-risk early breast cancer: Disease characteristics and endocrine therapy choice by menopausal status
Presenter: Shani Paluch-Shimon
Session: ePoster Display
154P - Five-year follow-up of the phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in patients with HER2 positive early or locally advanced breast cancer
Presenter: Xavier Pivot
Session: ePoster Display
242P - Impact of metastases directed radiation therapy on CDK4/6 inhibitors treatment for metastatic breast cancer
Presenter: Icro Meattini
Session: ePoster Display